Company Isodiol International Inc Canadian Securities Exchange
Equities
CA46500L1013
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Sales per region
CAD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 19 | 100.0 % | 22 | 100.0 % | +16.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 19-02-13 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 17-05-23 |
Director/Board Member | - | 18-08-29 | |
Director/Board Member | - | 18-11-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 98,334,359 | 98,334,359 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+37.65% | 6.04B | |
-19.68% | 4.27B | |
+4.49% | 3.28B | |
-15.69% | 2.96B | |
-5.64% | 2.43B | |
+44.89% | 1.93B | |
-12.71% | 1.59B | |
-4.27% | 1.58B | |
-14.86% | 1.5B |